Hologic : Second Quarter Fiscal 2024 Earnings Conference Call Transcript
REFINITIV STREETEVENTS EDITED TRANSCRIPT HOLX.OQ - Q2 2024 Hologic Inc Earnings Call ...
Source: marketscreener.com
📰 Thinprep Pap News
Thinprep Pap News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Thinprep Pap. Real-time updates on events, politics, business and more.
Hologic : Second Quarter 2024 Transcript
REFINITIV STREETEVENTS EDITED TRANSCRIPT HOLX.OQ - Q2 2024 Hologic Inc Earnings Call ...
Source: marketscreener.com
Hologic, Inc. (NASDAQ:HOLX) Q2 2024 Earnings Call Transcript
Hologic, Inc. beats earnings expectations. Reported EPS is $1.03, expectations were $0.97.
Source: insidermonkey.com
Hologic, Inc. Announces First and Only FDA-Cleared Digital Cytology System ? Genius? Digital Diagnostics System
Hologic, Inc. announced that its new Genius?? Digital Diagnostics System with the Genius?? Cervical AI algorithm has received clearance from the U.S. Food and Drug Administration , making it the first...
New Zealand Thinprep Pap Drug Administration Hologic Inc Digital Diagnostics System Genius Digital Diagnostics System
Source: marketscreener.com
Hologic Announces First and Only FDA-Cleared Digital Cytology System – Genius™ Digital Diagnostics System
Through a Combination of Advanced Imaging and Novel Artificial Intelligence, Latest Diagnostic System for Cervical Cancer Screening Can Help More Accurately Detect Disease, Improve Workflow and...
Source: marketscreener.com
Cervical Cancer Diagnostics Market size is expected to reach USD 13,022.1 million by 2030, rising at a market growth of 6.3% CAGR during the forecast period 2023 - 2030 |
Market Overview According to the DataM market research report, the global cervical cancer diagnostics market reached USD 8,042.9 million in 2022 and is
United States Asia Pacific Abbott Laboratories National Cervical Cancer Coalition Cardinal Health Quest Diagnostics
Source: medgadget.com
How the BD diagnostics business is driving greater access to care
It's been a busy time for BD, with recent approvals further driving the company's diagnostics business forward.
Source: massdevice.com
FDA approves BD Onclarity HPV assay for expanded use
BD (NYSE:BDX) announced today that it received FDA approval for its Onclarity HPV assay for use with the ThinPrep Pap Test.
Source: massdevice.com
Hologic's (HOLX) GAI Program to Include Aptima SARS-CoV-2 Assay
The addition of Aptima SARS-CoV-2 assay to Hologic's (HOLX) Global Access Initiative is likely to improve its accessibility.
Source: entrepreneur.com
La OMS busca erradicar el cáncer de cuello uterino en los próximos diez años
La OMS busca erradicar el cáncer de cuello uterino en los próximos diez años 12 Lectura: ( palabras) Para 2030, los objetivos trazados se basan en: 90% vacunación contra el virus del papiloma humano (VPH), 70% de detección y 90% de tratamiento de lesiones precancerosas Bogotá, julio de 2021. Según la Asamblea Mundial de la Salud, la cual promueve la estrategia para la eliminación del cáncer de cuello uterino (CaCu), se deben generar diferentes esfuerzos y acciones en las política...
Source: globedia.com